Oxidative Stress as a Therapeutic Target of Cardiac Remodeling

Danilo Martins1, Leonardo Rufino Garcia2, Diego Aparecido Rios Queiroz1

  • 1Internal Medicine Department, Botucatu Medical School, São Paulo State University (UNESP), Botucatu 01049-010, Brazil.

Insights

Cardiac remodeling involves changes in heart structure and function, contributing to heart failure. This review explores oxidative stress as a key therapeutic target to mitigate cardiac remodeling and prevent heart failure progression.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Cardiac remodeling encompasses molecular, cellular, and interstitial changes impacting heart size, mass, geometry, and function.
  • It plays a critical pathophysiological role in the development and progression of ventricular dysfunction and heart failure.
  • Numerous factors, including neurohormonal activation and reactive oxygen species, regulate cardiac remodeling.

Purpose of the Study:

  • To review the role of oxidative stress in cardiac remodeling.
  • To assess oxidative stress as a potential therapeutic target for mitigating cardiac remodeling.

Main Methods:

  • Literature review of studies investigating cardiac remodeling mechanisms.
  • Analysis of the role of reactive oxygen species and oxidative stress in cardiac remodeling.
  • Evaluation of therapeutic strategies targeting oxidative stress in cardiac remodeling.

Main Results:

  • Cardiac remodeling involves complex molecular and cellular alterations.
  • Oxidative stress emerges as a significant modulator of cardiac remodeling processes.
  • Targeting oxidative stress presents a promising therapeutic avenue.

Conclusions:

  • Oxidative stress is a key player in the pathophysiology of cardiac remodeling.
  • Therapeutic strategies aimed at reducing oxidative stress may offer benefits in managing cardiac remodeling and preventing heart failure.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K